These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2141683)

  • 1. p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis.
    Stürzbecher HW; Maimets T; Chumakov P; Brain R; Addison C; Simanis V; Rudge K; Philp R; Grimaldi M; Court W
    Oncogene; 1990 Jun; 5(6):795-81. PubMed ID: 2141683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53 nuclear localisation signal is structurally linked to a p34cdc2 kinase motif.
    Addison C; Jenkins JR; Stürzbecher HW
    Oncogene; 1990 Mar; 5(3):423-6. PubMed ID: 2156209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of synthetic peptide substrates for p34cdc2 protein kinase.
    Marshak DR; Vandenberg MT; Bae YS; Yu IJ
    J Cell Biochem; 1991 Apr; 45(4):391-400. PubMed ID: 2045431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase activity associated with immunopurified p53 protein.
    Kraiss S; Barnekow A; Montenarh M
    Oncogene; 1990 Jun; 5(6):845-55. PubMed ID: 2141685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning of the p53-dependent origin of cellular DNA replication.
    Iguchi-Ariga SM; Okazaki T; Itani T; Ariga H
    Oncogene; 1988 Nov; 3(5):509-15. PubMed ID: 2978868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse p53 blocks SV40 DNA replication in vitro and downregulates T antigen DNA helicase activity.
    Stürzbecher HW; Brain R; Maimets T; Addison C; Rudge K; Jenkins JR
    Oncogene; 1988 Oct; 3(4):405-13. PubMed ID: 2856250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells.
    Lock RB; Ross WE
    Cancer Res; 1990 Jun; 50(12):3761-6. PubMed ID: 2187601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine mapping and regulation of the association of p53 with p34cdc2.
    Wagner P; Fuchs A; Götz C; Nastainczyk W; Montenarh M
    Oncogene; 1998 Jan; 16(1):105-11. PubMed ID: 9467949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product.
    Ramos-Morales F; Domínguez A; Romero F; Luna R; Multon MC; Pintor-Toro JA; Tortolero M
    Oncogene; 2000 Jan; 19(3):403-9. PubMed ID: 10656688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tumor suppressors on cell cycle-regulatory genes: RB suppresses p34cdc2 expression and normal p53 suppresses cyclin A expression.
    Yamamoto M; Yoshida M; Ono K; Fujita T; Ohtani-Fujita N; Sakai T; Nikaido T
    Exp Cell Res; 1994 Jan; 210(1):94-101. PubMed ID: 8270002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression.
    Fiscella M; Ullrich SJ; Zambrano N; Shields MT; Lin D; Lees-Miller SP; Anderson CW; Mercer WE; Appella E
    Oncogene; 1993 Jun; 8(6):1519-28. PubMed ID: 8502477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells.
    Müller E; Boldyreff B; Scheidtmann KH
    Oncogene; 1993 Aug; 8(8):2193-205. PubMed ID: 8393163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse p53 inhibits SV40 origin-dependent DNA replication.
    Braithwaite AW; Sturzbecher HW; Addison C; Palmer C; Rudge K; Jenkins JR
    Nature; 1987 Oct 1-7; 329(6138):458-60. PubMed ID: 2821401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line.
    Romano JW; Ehrhart JC; Duthu A; Kim CM; Appella E; May P
    Oncogene; 1989 Dec; 4(12):1483-8. PubMed ID: 2531855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
    Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
    Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulated expression and phosphorylation of a possible mammalian cell-cycle control protein.
    Lee MG; Norbury CJ; Spurr NK; Nurse P
    Nature; 1988 Jun; 333(6174):676-9. PubMed ID: 3287181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of a protein kinase which is activated by SV40 large T-antigen and phosphorylates the tumor suppressor protein p53.
    Müller E; Scheidtmann KH
    Oncogene; 1995 Mar; 10(6):1175-85. PubMed ID: 7700642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2.
    Bischoff JR; Friedman PN; Marshak DR; Prives C; Beach D
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4766-70. PubMed ID: 2141171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of p53 in primary, immortalised and transformed Balb/c mouse cells.
    Patschinsky T; Deppert W
    Oncogene; 1990 Jul; 5(7):1071-6. PubMed ID: 2142761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of RNA polymerase by the murine homologue of the cell-cycle control protein cdc2.
    Cisek LJ; Corden JL
    Nature; 1989 Jun; 339(6227):679-84. PubMed ID: 2662013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.